Investor portal

A 20-year monopoly opportunity in a category that does not yet exist commercially.

Defended by patents we filed before the category was famous. Founded by people whose families and country were the original inspiration for caring about lost wisdom. Confidential briefing materials on request.

IP filings on record
TM + PPA + Utility
Patent priority date
2025-08-14
Academic manuscripts
11 in pipeline
Patent claims in code
8 of 11 implemented
Live infrastructure
Public · 24/7
Founders
2 inventors
Stage
Confidential
The pitch in three sentences
  1. AI Time Capsule is a patented architecture that turns the same foundation model into a faithful behavioral simulator of one specific person — without training a new model.
  2. Every response carries a cryptographic provenance log, distinguishing us from every chatbot in the category and satisfying EU AI Act Article 50 by construction.
  3. We hold the patent priority date the rest of the field is now chasing, and the live demo runs on our own infrastructure today.
Business model

Four revenue streams, one technical platform, one strategic outcome.

Phase 1
B2B — Corporate Knowledge Continuity

Capsules of retiring CTOs, chief engineers, and senior executives. Zero grief-tech legal risk. Founder-led enterprise sales motion. Designed to generate the first reference logos.

Phase 2
B2C — Family Legacy (Ancestor Pioneers)

Adults leaving a “living legacy” for grandchildren. Bereaved families reconstructing from existing data via Fast Capture Mode. Subscription model with family access tier.

Phase 2–3
B2H — Cultural Heritage / B2G

Living archives of cultural figures, last native speakers of endangered languages, master artisans, scientists. Funded by Mellon, NEH, NSF — non-dilutive.

Phase 3+
Therapeutic / Clinical — IRB-gated

Hospice and grief-counseling partnerships. FDA digital therapeutics submission. Clinical RCT before any consumer launch. Insurance reimbursement track.

Strategic outcome
License to a hyperscaler

Apple Memories. Google Photos. Meta. Microsoft. Each has the data and distribution; none has the patented architecture. We are positioned to license — not to compete head-on.

18-month milestones

Five concurrent tracks. Each with hard dates.

Q3 2026
research
Personality Test pilot complete (5 creators) → paper submitted to PLOS ONE / CHI 2026
Q3 2026
revenue
First B2B Corporate Knowledge Continuity LOI
Q4 2026
ip
US Utility Patent grant (Track One); Continuation-in-Part filed
Q1 2027
product
Mobile app (iOS + Android) with HealthKit / Health Connect
Q2 2027
research
50-creator Personality Test study, Science Advances submission
Q2 2027
revenue
First enterprise capsules in production; B2C waitlist conversions
Q3 2027
clinical
IRB-approved grief-therapy pilot with named hospice partner
Q4 2027
product
3D photoreal avatar + voice cloning at production fidelity
Due-diligence pack

Public-facing diligence materials. Confidential pack on request.

The materials below are public. The commercial pitch deck, capital plan, and IRB protocol templates are released on a confidentiality basis to qualified investors and counsel. Email either founder.

Contact

Direct line to both founders.

Rodion Sorokin
Lead Inventor & Technical Architect
s.rodion2009@gmail.com
Serhii Nikolaichuk
Visionary & Strategic Architect
nikolaichuk.s.f@gmail.com

Branded @aitimecapsule.com addresses will follow once the domain’s email is configured.